Background: Proliferative verrucous leukoplakia (PVL) is a progressive, multifocal, exophytic form of leukoplakia with high rates of malignant transformation. The purpose of this study was to evaluate a cohort of patients with PVL in a single tertiary referral clinic.
| I NT ROD UCTI ON
Proliferative verrucous leukoplakia (PVL) refers to a distinct but rare subset of oral leukoplakia. It is characterized by progressive, multifocal, exophytic lesions that are persistent, irreversible, and more common in elderly women without risk factors. [1] [2] [3] Although only characterized in 1985, 2 considerable attention has been paid to PVL because of high rates of recurrence, malignant transformation, and mortality. [1] [2] [3] However, controversy persists regarding diagnosis, etiology, and appropriate management. The diagnosis of PVL cannot be established on histopathological findings alone and requires correlation with a characteristic clinical appearance of progressive demarcated florid white lesions. 4 Major and minor diagnostic criteria based on both clinical and histopathological features have been suggested 5 and variously endorsed. 6 In their original account, Hansen et al 2 described a 10-point histological grading from 0 (normal) to 10 (frankly invasive squamous cell carcinoma), although a simplified scheme with 4 histopathological subtypes 4 has been published. It is accepted that some temporal progression in the clinical and pathological features is required before a diagnosis of PVL, implying, therefore, the need for retrospective review. 7 The differential diagnosis from other conditions has been described. 8 The etiology of PVL remains obscure, with no recognized risk factors other than advanced age and female sex. Although some early reports suggested a link between oncogenic viruses and PVL, 3,9 recent reports have not demonstrated an association with either highrisk human papillomavirus (HPV) subtypes or EpsteinBarr virus. [10] [11] [12] Owing to its progressive clinical course and tendency for malignant transformation, PVL has generally been aggressively managed. In a recent systematic review of 126 cases in which management was reported, surgery was used in 80%, radiotherapy in 24%, laser excision or ablation in 23%, and other treatment methods in a further 12%. 7 Most patients received multiple modalities and only 1.6% received no treatment, whereas 2.1% were managed conservatively with regular monitoring and multiple biopsies. The purpose of the present study was to undertake a retrospective evaluation of patients diagnosed with PVL in a multidisciplinary oral dysplasia clinic serving as a tertiary regional referral center. The clinical team serving this clinic was struck that management decisions seemed notably conservative compared with the published literature, and, therefore, wished to establish if this was the case, and the implications for outcomes. The demographic, clinical, histopathological characteristics, management, and clinical outcomes of our patients are compared with previous published cohorts. The HPV status was also established on a subset of this cohort.
| M ATE RI ALS AN D ME THOD S
An evaluation of patients diagnosed with PVL in a regional referral center for the period 1990-2015 was undertaken. Protocols for accepting new referrals, review, and management of premalignant lesions in this center have become increasingly formalized over the period. [13] [14] [15] Diagnostic criteria for and classification of PVL closely adhered to Hansen et al. 2 The histopathology for all cases was reexamined, with grades 3-5 usually considered to meet the histological requirement for an initial diagnosis of PVL. Cases in which there was uncertainty about the diagnosis of PVL, either from pathology, clinical course, or appearance, were excluded from analysis. After defining the index lesion and date of diagnosis, ongoing (and, sometimes, prior) management, including biopsy, treatment, malignant transformation, and death were recorded and assessed using the Kaplan-Meier analysis, and Mann-Whitney or Fisher's exact testing. In some cases, the confident diagnosis of PVL revealed a number of prior lesions or biopsies, which were then included in retrospect. Tobacco and alcohol exposure were recorded in keeping with our previous reports of premalignant lesions, 15 whereby smoking status was dichotomized as >5 pack-years, and alcohol use was >5 units per week as being long-term use. The site of PVL lesions was classified, and for those cases with 2 or more lesions in different sites, they were classified as multifocal. Determination of HPV status was undertaken for a subset of PVL cases for which formalin-fixed paraffin-embedded tissue blocks were retrieved. Data and tissue were collected under ethical approval (South Sefton Research Ethics Committee; EC47.01 and North West 5 Research Ethics Committee; 09/H1010/54). Tissue microarrays consisting of triplicate cores of representative PVL tissue from corresponding formalin-fixed paraffin-embedded tumor donor blocks were constructed according to standard protocols. The HPV detection was based on combined assessment of p16 immunohistochemistry (IHC) and high-risk HPV DNA in situ hybridization (ISH). A sample testing positive for both would confirm evidence of the presence of HPV DNA and the downstream effects of viral oncogene expression (p16 overexpression). Both p16 IHC and high-risk HPV DNA ISH analysis was conducted using proprietary kits (CINtec Histology, MTM Laboratories AG, Heidelberg, Germany; Inform HPV III Family 16 Probe B, Ventana Medical Systems, Tucson, AZ) on a Ventana Benchmark Autostainer (Ventana Medical Systems), as previously described. 16 Scoring of p16 IHC status was assessed using the widely used threshold of strong and diffuse nuclear and cytoplasmic staining in >70% of the tumor cells. High-risk HPV DNA ISH was scored using a binary classification (positive or negative) reflecting detection of chromogen in any of the tumor cells, as previously described. 17 
| R ES ULT S
After assessment of clinical and histopathological characteristics, 48 patients were diagnosed with PVL. The characteristics of histopathology at the first available biopsy are shown in Table 1 . A typical illustrative case showing many of the major and minor criteria for diagnosis of PVL is shown in Figures 1, 2 , 3, and 4. Seventy-seven percent of patients (n 5 37) presented with Hansen grades 3-5 on initial biopsy; 23% (n 5 11) of the cohort at both ends of the grading spectrum did not show features in keeping with the histopathology of conventional PVL at presentation. All patients were reviewed with a median follow-up of 3.4 years (interquartile range [IQR] 1.2-6.0 years) since diagnosis. The grading at the most recent available biopsy is also shown in Table 1 .
The demographic characteristics of patients and lesions were compared to the Bagan and Silverman cohorts 1, 3 and are shown in Table 2 , although some of the comparisons were limited by differing methodology (eg, history of tobacco and alcohol exposure was reported differently in the 3 cohorts).
In the current cohort, the site of lesions was pan-oral or multiple oral sites in 42% of the patients (20 patients), the gingivae only in 33% (16 patients), the tongue only in 13% (6 patients), the buccal only in 8% (4 patients), and other 4% (2 patients). Half of the patients (24 patients) were men. The largest total area of leukoplakia was measured for 46 patients at: 1000 mm 2 (20%; 9 patients), 500-999 mm 2 (30%; 14 patients), 250-499 mm 2 (20%; 9 patients), and <250 mm 2 (30%; 14 patients). Active surveillance and repeat biopsy in the event of clinical change in appearance were the most common method of management, used in 29 cases (60%). Surgical excision of premalignant lesions (Hansen grades 3-5) was performed in only 4 patients (8%), with 2 of those patients requiring marginal mandibular ("rim") resections and significant accompanying loss of dentition. Almost half of the patients (23; 48%) underwent malignant transformation and the median follow-up in those transformed was 8.2 years (IQR 4.6-14.5 years) and in those not transformed it was 3.5 years (IQR 1.2-9.7 years. Adjusting for variable follow-up using Kaplan-Meier survival (see Figure 5 ) the 5-year estimate of transformation was 4% (Standard Error (SE) 4%) and the 10-year estimate was 22% (SE 12%). The median time to transformation (time from PVL on initial biopsy to eventual, frankly invasive histology) was 23.4 months (IQR 0.4-55.0 months; n 5 23), and these patients had a median of 1 total number of diagnosed malignancies during their follow-up (IQR 1-3; range 1-9). A total of 6 patients (13%) died as a result of oral malignancy evolving from PVL.
Comparing the 23 patients who underwent malignant transformation with the 25 who did not, we found that age, sex, smoking status, or alcohol consumption were not different between the groups (Table 3 ). The larger lesions of PVL and pan-oral sites were statistically more likely to undergo malignant transformation. Gingival only lesions were statistically more likely not to progress to malignancy. There was a confounding association with patients with pan-oral PVL having larger lesions (14/20 with 500 mm 2 ) than singlesite lesions, such as gingival only (9/16 with <250 mm 2 ). Patients who underwent malignant transformation received significantly more biopsies than those who did not (median of 5 vs 1). Eighty-three percent (19/23) of transformed patients, all with multiple biopsies, showed a histological progression in grading. Figure 2 are magnified to illustrate the varying surface and front of proliferative verrucous leukoplakia (PVL). (Unless otherwise specified, the photomicrographs were taken at a 32 objective magnification.) A, Compact, verrucous hyperorthokeratosis on the surface. B, Finger-like exophytic papillary projections capped by hyperorthokeratosis with "shouldering" at the base. C, Exophytic mammillated projection with inconspicuous keratinization on the surface. D, Focally infolded/invaginated surface. E, Composite photomicrograph showing columns (arrow) and elephant feet-like arrangements (open arrow) of proliferative keratinocytes, which advance at more or less the same level; variable "lichenoid" inflammatory reaction is subadjacent to the advancing front. F, Gently mammillated surface and front advancing at different levels, although not extending to the submucosal fat (asterisk); inflammation is present between PVL and fat. G, Invaginated surface and front advancing at different levels and approaching salivary lobules (asterisk); the rectangled area is magnified in H to allow appreciation of cytology. H, The proliferative keratinocytes are often differentiated, but mitoses (arrow), densely stained nuclei (arrowhead) and perturbed stratification with absence of basal layer can be seen (objective magnification 310) [Color figure can be viewed at wileyonlinelibrary.com] Fifteen of 48 patients had adequate tissue for HPV testing. All 15 patients who were tested for HPV were negative in all tests.
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A notable finding of this retrospective study was that, in our largely conservatively managed (92%) cohort of patients with PVL, there were similar malignant transformation rates (48%) and fewer disease-related deaths (12.5%), when compared to the literature 1, 3, 7 (Table 2) . Large (>500 mm 2 ) panoral lesions present for a long duration of time (>8 years) were more likely to transform. It is also evident that the clinical progress of these lesions to malignancy seems slow and inexorable; therefore, the true impact of the disease is only apparent after prolonged longitudinal follow-up.
The inclusion criteria applied here allowed only patients with clinical and histopathological features of PVL who were treated within a specialist tertiary referral clinic to enter the study. The weaknesses of our data, in common with other published cohorts, lies in modest size and retrospective nature. Compared with the other cohorts in the published literature, 1, 3 ours has shorter follow-up (Table 2 ). This might partly explain that whilst the rate of malignant transformation is broadly similar in our cohort, the mortality is significantly lower. In addition, our cohort included rather similar numbers of lesions graded Hansen 6 and 7 (broadly corresponding to the less aggressive verrucous carcinoma) and Hansen 8 and 9 (broadly corresponding to the more aggressive conventional squamous cell carcinoma (10 and 12 cases, respectively; Table 1 ). Despite systematic attempts to precisely define PVL 6, 8 ), it is acknowledged that there remains some controversy around diagnostic not criteria, particularly for less typical cases.
The demographics of our cohort are comparable to the literature (ie, PVL mainly affecting elderly patients and apparently with little contribution from environmental carcinogens, such tobacco or alcohol). Our findings also support the lack of an etiological association between PVL and oncogenic HPV. 10, 12 We observed an equal representation of both men and women, which contrasts with the commonly reported female predominance, 7 and found no association between sex and malignant transformation or death. Gingivae are regarded as the most common site of PVL, 7 but our findings indicate multifocal disease (42% of patients) is more prominent than single-site presentation. Our cohort shows overall similar transformation rates and histological progression of PVL, as previously described. [1] [2] [3] We reemphasize the lack of evidence to support the routine excision of the noninvasive phase of PVL in an attempt to prevent future malignant transformation. Thus, our conservatively managed cohort is unique, and our data question the inference from other published series (ie, that empirical excision of PVL on presentation influences malignant transformation or survival). We would stress the need for careful and lifelong surveillance of patients with PVL in the context of a dedicated multidisciplinary team. Our aim is to diagnose emergent malignancies as early as possible and offer standard therapy based on the clinical staging of the emergent squamous cell carcinoma. The certainty behind any recommendation is currently weak, and we acknowledge the paucity of high-quality data to inform treatment decisions for PVL. However, the morbidity of surgical excision of PVL is sometimes considerable, particularly the accumulated effects of repeat surgery. If this is carried out without sufficient evidence of benefit, it might reasonably be open to question. We have experienced that adequate excision of widespread gingival lesions often requires loss of alveolar process and many or all of the patient's teeth. Bearing in mind that this group of patients have the lowest risk of malignant transformation of all PVL sites, we find it particularly difficult to recommend this intervention. There is a need for greater awareness in the medical and dental communities of the existence of PVL and the importance of specialist management. Histopathological grading on first biopsy cannot be used in isolation to safely direct management and clinical factors, such as the appearance of the lesion and temporal trends, are also crucial. In view of the relative rarity of PVL, multicenter collaborative studies are desirable to better evaluate diagnosis and management and establish more meaningful diagnostic and treatment guidelines for clinicians. Furthermore, the high transformation rates of PVL in conjunction with the lack of an obvious effect of smoking status and alcohol consumption suggest a role of as yet uncharacterized molecular aberrations. With the aid of modern genomic platforms, it may now be possible to identify the critical etiological events that underlie the pathogenesis of this clinicopathological challenging condition. 
